Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elena Biagioli

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Springerplus|February 18, 2016
Role of patient and tumor characteristics in sentinel lymph node metastasis in patients with luminal early breast cancer: an observational studyNicla La Verde, Elena Biagioli, Chiara Gerardi, et al.
Advances in Therapy|June 18, 2016
Latanoprost and Dorzolamide for the Treatment of Pediatric Glaucoma: The Glaucoma Italian Pediatric Study (Gipsy), Design and Baseline CharacteristicsLuciano Quaranta, Elena Biagioli, Francesca Galli, et al.
Journal of Glaucoma|August 11, 2018
The Glaucoma Italian Pediatric Study (GIPSy): 3-Year ResultsLuciano Quaranta, Elena Biagioli, Ivano Riva, et al.
Pain Practice : the Official Journal of World Institute of Pain|October 25, 2018
Systematic Review and Meta-Analysis on Neuropsychological Effects of Long-Term Use of Opioids in Patients With Chronic Noncancer PainNicola Allegri, Simona Mennuni, Eliana Rulli, et al.
Journal of Neuro-Oncology|February 7, 2019
Multicenter, single arm, phase II trial on the efficacy of ortataxel in recurrent glioblastomaAntonio Silvani, Irene De Simone, Vittorio Fregoni, et al.
Plos One|December 7, 2017
The prognostic role of tumor size in early breast cancer in the era of molecular biologyAnaid Anna Kasangian, Giorgio Gherardi, Elena Biagioli, et al.
Gynecologic Oncology|February 9, 2025
Rechallenge with platinum-based chemotherapy in patients with platinum-resistant ovarian carcinoma: A cohort studyCarmine Valenza, Marta Mongillo, Maria Vittoria Visconti, et al.
Health Services Insights|April 20, 2023
Centre for Statistical and Methodological Excellence (CESAME): A Consortium Initiative for Improving Methodology in Randomised Clinical TrialsCaroline Kamp Jørgensen, Markus Harboe Olsen, Niklas Nielsen, et al.
British Journal of Cancer|July 31, 2018
A phase II randomised (calibrated design) study on the activity of the single-agent trabectedin in metastatic or locally relapsed uterine leiomyosarcomaAngiolo Gadducci, Federica Grosso, Giovanni Scambia, et al.
Gynecologic Oncology|January 22, 2022
Randomized phase II trial of weekly paclitaxel vs. cediranib-olaparib (continuous or intermittent schedule) in platinum-resistant high-grade epithelial ovarian cancerNicoletta Colombo, Federica Tomao, Pierluigi Benedetti Panici, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Springerplus|February 18, 2016
Role of patient and tumor characteristics in sentinel lymph node metastasis in patients with luminal early breast cancer: an observational studyNicla La Verde, Elena Biagioli, Chiara Gerardi, et al.
Advances in Therapy|June 18, 2016
Latanoprost and Dorzolamide for the Treatment of Pediatric Glaucoma: The Glaucoma Italian Pediatric Study (Gipsy), Design and Baseline CharacteristicsLuciano Quaranta, Elena Biagioli, Francesca Galli, et al.
Journal of Glaucoma|August 11, 2018
The Glaucoma Italian Pediatric Study (GIPSy): 3-Year ResultsLuciano Quaranta, Elena Biagioli, Ivano Riva, et al.
Pain Practice : the Official Journal of World Institute of Pain|October 25, 2018
Systematic Review and Meta-Analysis on Neuropsychological Effects of Long-Term Use of Opioids in Patients With Chronic Noncancer PainNicola Allegri, Simona Mennuni, Eliana Rulli, et al.
Journal of Neuro-Oncology|February 7, 2019
Multicenter, single arm, phase II trial on the efficacy of ortataxel in recurrent glioblastomaAntonio Silvani, Irene De Simone, Vittorio Fregoni, et al.
Plos One|December 7, 2017
The prognostic role of tumor size in early breast cancer in the era of molecular biologyAnaid Anna Kasangian, Giorgio Gherardi, Elena Biagioli, et al.
Gynecologic Oncology|February 9, 2025
Rechallenge with platinum-based chemotherapy in patients with platinum-resistant ovarian carcinoma: A cohort studyCarmine Valenza, Marta Mongillo, Maria Vittoria Visconti, et al.
Health Services Insights|April 20, 2023
Centre for Statistical and Methodological Excellence (CESAME): A Consortium Initiative for Improving Methodology in Randomised Clinical TrialsCaroline Kamp Jørgensen, Markus Harboe Olsen, Niklas Nielsen, et al.
British Journal of Cancer|July 31, 2018
A phase II randomised (calibrated design) study on the activity of the single-agent trabectedin in metastatic or locally relapsed uterine leiomyosarcomaAngiolo Gadducci, Federica Grosso, Giovanni Scambia, et al.
Gynecologic Oncology|January 22, 2022
Randomized phase II trial of weekly paclitaxel vs. cediranib-olaparib (continuous or intermittent schedule) in platinum-resistant high-grade epithelial ovarian cancerNicoletta Colombo, Federica Tomao, Pierluigi Benedetti Panici, et al.
Pageof 4